Table 2. (d) Dabigatran.
| CKD | Non-CKD | P value | |
|---|---|---|---|
| N | 140(28.3) | 353(71.7) | |
| Age (years) | 79.1±6.9 | 66.1±9.5 | <0.01 |
| Male (%) | 54 | 72 | <0.01 |
| Appropriate dose (%) | 93.6 | 72.6 | <0.01 |
| Body-weight (kg) | 50.2±9.1 | 63.0±10.3 | <0.01 |
| Ccr (ml/min) | 40.4±7.3 | 77.9±26.0 | <0.01 |
| CHADS2 score | 2.58±1.35 | 1.57±1.13 | <0.01 |
| CHA2DS2-VASc score | 4.11±1.51 | 2.52±1.47 | <0.01 |
| HAS-BLED score | 2.24±0.96 | 1.63±0.94 | <0.01 |
| Any cause death (per 100-patient years) | 0.6 | 0.1 | 0.45 |
| Major bleeding (per 100-patient years) | 2.5 | 1.4 | 0.48 |
| Stroke/systemic emboli (per 100-patient years) | 3.8 | 1.7 | 0.23 |